IRF4: Immunity. Malignancy! Therapy?
- 30 April 2009
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (9), 2954-2961
- https://doi.org/10.1158/1078-0432.ccr-08-1845
Abstract
IRF4, a member of the Interferon Regulatory Factor (IRF) family of transcription factors, is expressed in cells of the immune system, where it transduces signals from various receptors to activate or repress gene expression. IRF4 expression is a key regulator of several steps in lymphoid-, myeloid-, and dendritic-cell differentiation, including the differentiation of mature B cells into antibody-secreting plasma cells. IRF4 expression is also associated with many lymphoid malignancies, with recent evidence pointing to an essential role in multiple myeloma, a malignancy of plasma cells. Interference with IRF4 expression is lethal to multiple myeloma cells, irrespective of their genetic etiology, making IRF4 an “Achilles' heel” that may be exploited therapeutically.Keywords
This publication has 92 references indexed in Scilit:
- IRF-4-Binding Protein Inhibits Interleukin-17 and Interleukin-21 Production by Controlling the Activity of IRF-4 Transcription FactorImmunity, 2008
- Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomasLeukemia, 2008
- Interferon regulatory factor 4 and 8 in B-cell developmentTrends in Immunology, 2008
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- IRF4 addiction in multiple myelomaNature, 2008
- Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaNew England Journal of Medicine, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000